UNBS5162 是一种新型萘酰亚胺，可降低实验性前列腺癌中 CXCL 趋化因子的表达。它是一种广谱趋化因子配体CXCL拮抗剂，具有抗肿瘤活性。

UNBS-5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.

956590-23-1

C17H18N4O3

326.356

UNBS 5162;UNBS-5162

DMSO:10 mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years